switching glp 1 PDF] Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance 5 things to know before

Yu J, et al

ChPL semaglutydu w postaci wstrzykni wskazuje, e produkt jest przeznaczony dla dorosych z niedostatecznie kontrolowan cukrzyc typu 2, cznie z odpowiedni diet i wysikiem fizycznym - w monoterapii, gdy metformina jest niewskazana, lub w skojarzeniu z innymi lekami przeciwcukrzycowymi

It is a dietary supplement

Sitagliptin phosphate blocks the degradation of glucagon -like peptide-1 ( GLP-1 ) and glucose-dependent insulinotropic peptide ( GIP ) by competing inhibition mechanism ( K = 1 nM), thereby increasing the level of active incretin

These medications help reduce appetite and improve blood sugar control, making them a valuable tool for individuals struggling with obesity and diabetes

For patients, the studys message is simple but urgent: not all GLP-1 offerings are built the same way